Ticker

Beacon Pointe Advisors LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 363,066 shares of the company's stock, valued at approximately $46,655,000. Beacon Pointe Advisors LLC owned about

Blue Edge Capital LLC lowered its holdings in Merck KGaA (OTCMKTS:MKGAF) by 39.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,499 shares of the company's stock after selling 7,392 shares during the period. Blue Edge Capital LLC's

Bamco Inc. NY purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,000 shares of the company's stock, valued at approximately $2,827,000. Other hedge funds and other institutional investors

ADAR1 Capital Management LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,140 shares of the company's stock, valued at approximately $403,000. Other institutional investors have also recently bought and

Ancora Advisors LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 20,902 shares of the company's stock, valued at approximately $2,686,000. Several other institutional investors and hedge